Nipro Of Japan Allies With Novartis To Develop, Produce Generics
This article was originally published in PharmAsia News
Executive Summary
Japan's Nipro is joining with Swiss-based Novartis, acting through its Japan unit, Sandoz, to develop and make generic drugs aimed at Japanese patients